ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

APGE Apogee Therapeutics Inc

41.14
-1.98 (-4.59%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Apogee Therapeutics Financial Summary

The current APGE market cap is 2.08B. The company's latest EPS is USD -1.6580 and P/E is -24.80.

Quarter End Sep 2023Dec 2023Mar 2024
USD (US$)
Total Revenue 000
Operating Income -24.31M-42.6M-38.18M
Net Income -20.84M-31.74M-32.09M
Year End December 30 2023 2023
USD (US$)
Total Revenue 0
Operating Income -93M
Net Income -83.99M
Quarter End Sep 2023Dec 2023Mar 2024
USD (US$)
Total Assets 426.42M401.4M823.66M
Total Liabilities 17.18M21.49M22.18M
Total Equity 409.24M379.91M801.48M
Year End December 30 2023 2023
USD (US$)
Total Assets 401.4M
Total Liabilities 21.49M
Total Equity 379.91M
Quarter End Sep 2023Dec 2023Mar 2024
USD (US$)
Operating -45.01M-74.76M-31.64M
Investing -234.22M-273.91M-51.74M
Financing 315.6M315.39M450.52M
Year End December 30 2023 2023
USD (US$)
Operating -74.76M
Investing -273.91M
Financing 315.39M
Market Cap 2.08B
Price to Earnings Ratio -24.80
Price to Sales Ratio 0
Price to Cash Ratio 17.61
Price to Book Ratio 5.48
Dividend Yield -

Share Statistics

Shares Outstanding 50.66M
Average Volume (1 week) 342.62k
Average Volume (1 Month) 372.94k
52 Week Change 91.35%
52 Week High 72.29
52 Week Low 14.19
Spread (Intraday) 3.42 (8%)

Company Info

Company Name Apogee Therapeutics Inc
Address 1209 orange st
wilmington, delaware 19801
Website https://www.apogeetherapeutics.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock